US Archives - Page 148 of 216 - European Medical Journal

Landmark Migraine Study Identifies 778 Genetic Risk Variants in Veterans: AAN 2025

A genome-wide association study (GWAS) presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego has identified 778 previously unknown genetic variants associated with migraine, shedding new light on the condition’s genetic underpinnings across racial and ethnic groups.

New Criteria Improve Diagnosis of IgG4-Related Arterial Disease

Healthcare professionals in the U.S. are closely watching progress in the diagnosis and management of IgG4-related periaortitis, periarteritis, and retroperitoneal fibrosis, a complex subset of IgG4-related disease (IgG4-RD) that mimics other conditions and defies simple diagnostic approaches.

Phototherapy Plus Antioxidants Top Vitiligo Treatments

In a new network meta-analysis evaluating treatments for vitiligo, researchers have identified the most effective combinations of phototherapy and topical therapies, offering clinicians fresh insights into optimizing patient outcomes.

Researchers Explore Stool Testing for Tuberculosis in HIV

In a multicenter prospective study, researchers found that a stool-based tuberculosis test could help detect TB in adults living with HIV, particularly among those with low CD4 counts.

Inspire Study Links Spinal Stimulation to Recovery in Diabetic Neuropathy: AAN 2025

At the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, researchers presented late-breaking data from the Inspire Study, a trial exploring spinal cord stimulation (SCS) as a holistic treatment for painful diabetic peripheral neuropathy (pDPN).

Parkinson’s Symptoms Improved in TEMPO-2 Trial: AAN 2025

New results from the Phase III TEMPO-2 trial, presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, indicate that flexible-dose tavapadon significantly improved motor symptoms and daily functioning in adults with early Parkinson’s disease (PD), compared with placebo.

AAD 2025 Interview: Lindsay Ackerman

It’s phenomenally satisfying to see the investments that the industry has made in trying to continue to move the needle forward in the…

Patient Decision Aids Impact Skin Cancer Choices

A new study on superficial basal cell carcinoma treatment decisions highlights that patient decision aids may subtly shift treatment preferences, with keywords such as superficial basal cell carcinoma, patient decision aid, non-invasive treatment, and effective decision-making underscoring the research.

Lorazepam Treatment Enhanced by Phenobarbital in Alcohol Withdrawal Syndrome Outcomes

In hospitalized patients with alcohol withdrawal syndrome (AWS), early addition of phenobarbital to lorazepam-based treatment significantly reduces the length of stay and the need for mechanical ventilation compared to dexmedetomidine, according to a new retrospective study conducted in a U.S. tertiary hospital.

Can Genomic Testing Improve Your Melanoma Management?

This infographic explores how genomic testing, specifically the 31-GEP test, can enhance melanoma management by providing personalized risk…